These findings highlight the lack of awareness regarding necessary adjustments in drug dosing and frequency based on changing drug excretion rates, underscoring the importance of including CP in the multidisciplinary team to ensure proper dosing in patients with renal dysfunction. This evidence concerns the gene CP and Abnormal renal physiology.